rs372307204
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4BS1_SupportingBS2
The NM_006306.4(SMC1A):āc.3186C>Gā(p.Ile1062Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000992 in 1,209,802 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 33 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_006306.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMC1A | NM_006306.4 | c.3186C>G | p.Ile1062Met | missense_variant | 21/25 | ENST00000322213.9 | NP_006297.2 | |
SMC1A | NM_001281463.1 | c.3120C>G | p.Ile1040Met | missense_variant | 22/26 | NP_001268392.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMC1A | ENST00000322213.9 | c.3186C>G | p.Ile1062Met | missense_variant | 21/25 | 1 | NM_006306.4 | ENSP00000323421.3 |
Frequencies
GnomAD3 genomes AF: 0.0000358 AC: 4AN: 111779Hom.: 0 Cov.: 22 AF XY: 0.0000295 AC XY: 1AN XY: 33945
GnomAD3 exomes AF: 0.0000273 AC: 5AN: 183103Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67573
GnomAD4 exome AF: 0.000106 AC: 116AN: 1098023Hom.: 0 Cov.: 31 AF XY: 0.0000881 AC XY: 32AN XY: 363383
GnomAD4 genome AF: 0.0000358 AC: 4AN: 111779Hom.: 0 Cov.: 22 AF XY: 0.0000295 AC XY: 1AN XY: 33945
ClinVar
Submissions by phenotype
Congenital muscular hypertrophy-cerebral syndrome Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 05, 2020 | This variant has not been reported in the literature in individuals with SMC1A-related disease. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). This variant is present in population databases (rs372307204, ExAC 0.002%). This sequence change replaces isoleucine with methionine at codon 1062 of the SMC1A protein (p.Ile1062Met). The isoleucine residue is moderately conserved and there is a small physicochemical difference between isoleucine and methionine. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Sep 12, 2017 | - - |
Congenital muscular hypertrophy-cerebral syndrome;C5393312:Developmental and epileptic encephalopathy, 85, with or without midline brain defects Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 16, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at